HCG on TRT: Dosing, Timing, and What it Actually Does
Written by Adam Maggio | Medically reviewed by Dr. Sarah Chen, PharmD, BCPS
Human Chorionic Gonadotropin (HCG) mimics LH, stimulating Leydig cells to produce testosterone and maintaining testicular size and function during TRT. Typical dosing ranges from 500-1000 IU subcutaneously 2-3 times weekly, often initiated concurrently with TRT to prevent testicular atrophy and preserve fertility.
HCG on TRT: Dosing, Timing, and What It Actually Does
For men undergoing Testosterone Replacement Therapy (TRT), the addition of Human Chorionic Gonadotropin (HCG) is a common strategy to mitigate specific side effects, primarily testicular atrophy and impaired fertility. HCG acts as a luteinizing hormone (LH) analog, directly stimulating the Leydig cells within the testes to produce endogenous testosterone and maintain testicular function [1]. This action is crucial because exogenous testosterone suppresses the pituitary gland's release of LH and follicle-stimulating hormone (FSH), leading to a reduction in natural testosterone production and spermatogenesis [2].
Mechanism of Action: How HCG Works with TRT
When a man initiates TRT, the body's endocrine system detects sufficient testosterone levels and reduces its own production of gonadotropins (LH and FSH) from the pituitary. LH is the primary signal for Leydig cells to produce testosterone, and FSH is essential for initiating and maintaining spermatogenesis in the Sertoli cells. Without these signals, the testes can shrink (atrophy) and sperm production can cease, leading to infertility [2].
HCG bypasses the suppressed pituitary by directly binding to LH receptors on the Leydig cells. This direct stimulation prompts the testes to continue producing testosterone, maintaining intratesticular testosterone levels that are vital for sperm development. It also helps preserve testicular size and function, preventing the atrophy commonly associated with TRT monotherapy [1, 3].
Dosing and Timing Protocols for HCG on TRT
Clinical protocols for HCG administration alongside TRT typically involve low, divided doses to mimic the pulsatile release of natural LH and maintain stable testicular stimulation. Common dosing regimens include:
- 250-500 IU administered subcutaneously two to three times per week [1, 4]. This frequency helps maintain consistent HCG levels and continuous testicular stimulation.
- Some protocols may use 125 IU or 250 IU every other day [5].
- Prevention of Testicular Atrophy: HCG helps maintain testicular volume, preventing the shrinkage that often occurs with TRT alone. This can have psychological benefits for patients and may also contribute to overall testicular health [1, 3].
- Support for Endogenous Testosterone Production: While on TRT, the body's natural testosterone production is suppressed. HCG ensures that the testes continue to function, producing some natural testosterone, which can contribute to overall well-being and potentially reduce reliance on exogenous testosterone [3].
The specific dose and frequency can vary based on individual response, the patient's goals (e.g., fertility preservation vs. testicular size maintenance), and the duration of TRT. For most men on maintenance TRT, lower, more frequent dosing is preferred to avoid overstimulation and potential desensitization of Leydig cells.
Clinical Benefits of Adding HCG to TRT
The primary benefits of incorporating HCG into a TRT regimen include:
1. Preservation of Fertility: By maintaining intratesticular testosterone levels and stimulating spermatogenesis, HCG can help preserve a man's ability to produce sperm, which is crucial for those who may desire future children [1, 3].
HCG vs. TRT Monotherapy
TRT monotherapy effectively raises systemic testosterone levels, alleviating symptoms of hypogonadism like low libido, fatigue, and mood disturbances. However, it comes at the cost of suppressing natural testosterone production and often leading to testicular atrophy and infertility. HCG, when added to TRT, directly addresses these specific side effects by maintaining testicular function. While TRT monotherapy is simpler, the combination therapy offers a more comprehensive approach for men concerned about fertility or testicular size. The decision between TRT monotherapy and TRT with HCG depends on individual patient goals, particularly regarding reproductive plans.
Clinical Takeaway
For men on TRT, HCG is a valuable adjunctive therapy, typically dosed at 250-500 IU subcutaneously two to three times weekly, to preserve testicular function and fertility. It directly stimulates Leydig cells, maintaining intratesticular testosterone and preventing atrophy, thereby counteracting the suppressive effects of exogenous testosterone on sperm production. This nuanced approach allows men to benefit from TRT while safeguarding their reproductive potential.